INTRODUCTION
At the mucosa of the intestine, a single layer of epithelial cells separates the host tissue from the immunostimulatory content of the gut lumen such as microbes, nutrients, and metabolites. In order to maintain tolerance but still be able to mount potent immune responses, the mucosal immune system is equipped with various special immune cell types that are very rare in secondary lymphoid organs. One of these mucosa-associated immune cells are intraepithelial lymphocytes (IELs) that are interspersed at the basolateral side of epithelial cells. Here they fulfill important functions in the maintenance of the epithelial barrier by promoting cellular turnover of the epithelium, providing first-line responses against pathogens and tumors, and also regulating overt immune responses to limit collateral damage to the intestinal barrier. 1 Developmentally, two types of IELs can be distinguished. Induced IELs are the progeny of conventional CD4 and CD8ab T cells after they have engaged their cognate antigen in the periphery, e.g., during an infection. Thus, induced IELs are rare in newborn or germ-free mice and accumulate over time in conventionally housed mice. In contrast, natural IELs are fate determined during thymic development, have an oligoclonal 2 and skewed T cell receptor (TCR) repertoire toward self, 3 and can be found in normal numbers in germ-free mice. 4 Natural IELs are composed of DN (double negative; i.e., lacking expression of CD4 or CD8ab) gd þ T cells as well as ab þ T cells, with the large majority of cells expressing the homodimer CD8aa that can bind the nonclassical major histocompatibility complex, class I (MHC I) molecule thymic leukemic antigen. 5 It has been reported that expression of the CD8aa homodimer in the thymus defines the earliest preselection precursors of IELs that in addition coexpress CD4 and CD8ab and are therefore called triple-positive thymocytes. 6 In contrast to conventional T cells, natural TCRab þ IELs are generated in the thymus by interaction with high-affinity ligands presented on classical and nonclassical MHC I molecules, a process coined as agonist selection. 6 Evidently, the majority of these cells will undergo apoptosis during negative selection.
Nevertheless, some cells will receive, yet unknown, survival signals, divert from clonal deletion, and further differentiate into IELs. This sequence of events is clearly supported by recent reports that have shown that the TCR specificity against self appeared to be the primary determinant of natural TCRab þ IEL lineage commitment. 8, 9 Postselection IEL precursors (IELPs) downregulate CD4 and CD8ab (DN) and are now defined by expression of the rearranged TCR, upregulation of CD5 and CD90, as well as lack of NK1.1 to exclude natural killer T (NKT) cells (DN TCRb þ CD5 þ CD90 þ NK1.1 À ¼ IELPs). 6 Subsequently, IELPs leave the thymus and migrate to the epithelium of the small intestine, a process that is guided by CCR9 and b 7 integrins. 10 Upon arrival in the epithelial niche, the cells downregulate CD5 and CD90 and upregulate CD103 and CD8aa, a process that is dependent on interleukin-15 (IL-15) trans-presented by intestinal epithelial cells. As outlined, much has been learned about the stepwise process of thymic development and the TCR specificity of natural TCRab þ IELs. However, the transcriptional programs that govern these processes have just started to be explored. Recently, we 4 and others 12 have shown that the T-box transcription factor T-bet plays a nonredundant and cellintrinsic role in the development of both TCRab and TCRgd natural IELs. T-bet is not required for thymic IEL commitment but is necessary for the IL-15-driven expansion and differentiation of thymic IELPs. 4 The common definition of thymic IELPs as DN TCRb
À must be treated with caution, as this would imply a homogeneous population. Intriguingly, in vivo transfer of IELPs cells gave rise to not only natural TCRab þ IELs T cells but also a very sizeable number of CD8ab þ T cells, arguing that these cells contain a heterogeneous population of precursors. 4, 6, 13 In addition, transcription factors like Egr2 or Helios, where the latter marks thymocytes with a history of strong agonist interaction, are not uniformly expressed in IELPs, further questioning the homogeneity of this population. Finally, T-bet is only expressed in a minority of Helios þ IELPs, whereas it is expressed in virtually all natural IELs. 4 Hence, we focused on T-bet to more accurately define a population of natural IELPs. We used recently developed T-bet reporter mice (Tbx21 ZsGreenTg , hereafter called TBGR mice 14 ) to characterize and follow the fate of T-bet þ IELPs. T-bet þ IELPs are mature thymocytes (H2-K b þ CD24 À Qa2 high ) that egress from the thymus in a sphingosine-1-phosphate (S1P) dependent manner that can be blocked with FTY720. By crossing TBGR mice with Tbx21 À / À and Il15 À / À mice, we also demonstrate that T-bet does not regulate its own expression in IELPs and has no effect on the final maturation of H2-K b þ CD24 -IELPs. In contrast, IL-15 acts at least via two mechanisms on IELPs. First, by boosting the expression of T-bet from a T-bet intermediate (int) to a T-bet high status and, second, by guiding the maturation of H2-K b þ CD24 -IELPs, that is independent of T-bet Finally, use of TBGR mice allowed us to sort T-bet þ IELPs to high purity. Differentiation experiments in vivo and in vitro showed a clear correlation between T-bet expression and a lack of differentiation potential into conventional CD8ab þ T cells.
RESULTS

A fraction of IELPs in the thymus expresses T-bet
In order to analyze the developmental potential of thymic T-bet þ IELPs, we wanted to make use of recently generated bacterial artificial chromosome transgenic TBGR mice.
14 It has been established that the reporter faithfully reflects T-bet expression in T helper type1 cells, but its usefulness in innatelike lymphocytes, e.g., IELs and NKT cells, has not been addressed so far. We have recently documented that IELs uniformly express the transcription factor T-bet and that T-bet is indispensable for development of CD8aa þ TCRab þ and TCR gd þ T cells in the epithelium of the small intestine. 4 Using TBGR mice, we confirmed expression of ZsGreen (T-bet) in TCRab þ CD8aa þ and TCRab þ CD8ab þ as well as TCRgd þ IELs by flow cytometry and immunofluorescence (see Figure 1b , for gating see Supplementary Figure S1b ) and which in addition expressed high levels of CD122. Moreover, ZsGreen expression in flow cytometry corresponded extremely well with Tbx21 mRNA and T-bet protein expression in thymic subsets ( Figure 1c and Supplementary Figure S1c) . Next, we wanted to determine the thymic niche of IELPs by immunofluorescence using a similar approach. However, we were unable to establish a reliable staining for NK1.1. Nevertheless, immunofluorescence analysis of thymi from TBGR mice revealed that T-bet þ cells were largely localized in the cytokeratin 5 (CK5)-positive thymic medulla (Figure 1e ) that also includes T-bet þ NK and NKT cells. T-bet expression in IELPs correlated well with progressive development as T-bet þ (ZsGreen) IELPs were positive for the MHC class I molecule H2-K b , CD122, and Qa2, and partially negative for CD24 (Figure 1f ). Detailed analysis of the coexpression of thymic maturation markers CD24 and H2-K b showed that T-bet expression increased with thymic development, whereby T-bet high IELPs were CD24 -H2-K b þ (Figure 1f,g ). 15 The superior brightness and dynamic range of ZsGreen was also largely maintained during intranuclear flow cytometry. Hence, we initially confirmed our previous data that the overwhelming majority of T-bet þ IELPs are Helios þ (Figure 1h ), a marker that strongly correlates with strong agonist selection in the thymus. Intriguingly, T-bet þ IELPs were negative for Nur77 (Figure 1h ), whose expression also indicates the strength of the TCR stimulus in conventional T cells and CD4
þ regulatory T cells. This phenotype is however not unprecedented among agonist-selected innate-like T cells and is shared with T-bet þ NK1.1 þ iNKT cells (stage 3) that transiently upregulate Nur77 (stage 0) and then gradually loose it during thymic development. 16 Similar to CD4 and CD8 single-positive thymocytes, ZsGreen high (i.e., T-bet high ) IELPs egress from the thymus in a S1P-dependent manner that can be blocked by treating TBGR mice with FTY720 for 14 days (Figure 1i À T-bet À , CD122 þ T-bet À , and CD122 þ T-bet þ IELPs (as gated in bottom row of a) are given for the different cell populations and time points as described in (a). *Po0.05; **Po0.01; and ***Po0.001.
periphery. Indeed, mice treated with FTY720 showed a tendency toward a decreased frequency of TCRab þ
CD8ab
À IELs in the intestinal epithelium (Supplementary Figure S2a) Figure S2b) were overrepresented. This would imply that despite the accumulation of T-bet int/high IELPs in the thymus after FTY720 treatment, a significant proportion of IELPs leave the thymus before they express T-bet. The FTY720 experiments are in agreement with a recent report that implicated that thymic CD8aa
þ IELPs leave the thymus in a S1P1-dependent manner and therefore mice with a conditional knockout for S1pr1 (encodes for S1P1) in the hematopoietic system have severely reduced numbers of TCRab þ CD8aa þ and TCRgd þ IELs. 17 In order to better understand the regulation of T-bet we crossed TBGR mice with Tbx21 À / À and Il15 À / À mice, respectively. Tbx21 Figure S2c) .
In summary, TBGR mice show a faithful expression of the reporter as a surrogate for T-bet in natural IELs and their thymic precursors and can thus be used to analyze the role of T-bet in IEL development.
Thymic ontogeny of T-bet þ IELPs
It has been shown for TCRgd þ T cells that specific subsets arise during discrete time windows before or after birth in the thymus and subsequently migrate to their destined peripheral organ. As TCRab þ CD8aa þ IELs share many features with TCRgd þ CD8aa þ IELs we next explored their thymic and peripheral development after birth in TBGR mice. At 1 week after birth (0.25 month), only small numbers of IELPs could be detected in the thymus. Nevertheless, a clear population of T-bet þ (i.e., ZsGreen þ ) could already be identified at this stage ( Figure 2a , left column, and Figure 2b , bottom row). In the following week (0.5 month) we noticed a striking and significant increase in the percentage and absolute numbers of IELPs and T-bet þ IELPs (Figure 2a , second column, and Figure 2b , bottom row) that is in agreement with the appearance of thymic IELPs in TCR transgenic mouse strains. 15 The absolute number of T-bet þ IELPs did not change significantly over the following months (Figure 2a,b) . Intriguingly, it appeared that within the first month of life T-bet þ IELPs did not reach the very high levels of T-bet that can be seen at later stages in life (compare MFI for ZsGreen in 0.25, 0.5, and 1 month vs. 3 and 6 months). However, because of high variance, that difference did not reach statistical significance. In summary, we can conclude that in contrast to some subsets of TCRgd þ T cells the absolute numbers of T-bet þ IELPs increase over the first 2 weeks of life and then remain constant for the time hereafter.
Intestinal ontogeny of IELs
The intestinal appearance of natural TCRab 5 month) . Thereafter, the number of all IEL populations increased gradually until they maintained stable numbers between 3 and 6 months. One intriguing finding at weeks 1 and 2 was the fact that these were the only time points at which the number of TCRab þ CD8ab À IELs was equal or even higher than the number of TCRab þ CD8aa þ IELs (Figure 3a , first two columns, and Figure 3c ). At these stages, and similar to thymic IELPs, with which they share the phenotype DN TCRb þ NK1.1 À , TCRab þ CD8ab À IELs do not uniformly express T-bet (Figure 3d ,e, middle bar diagram), suggesting that they might be recent thymic emigrants (RTEs) and the precursors of TCRab þ CD8aa þ IELs; a hypothesis that we tested later in this study (see Figure 5) . In contrast and independent of age, TCRab þ CD8aa þ IELs were virtually all T-bet þ (Figure 3d ,e, left bar diagram).
Expression of T-bet in IELPs is correlated with strongly decreased CD8ab þ T-cell differentiation potential
We hypothesized before that T-bet þ IELPs are committed to an unconventional T-cell fate and lack potential to differentiate into conventional T cells. To test this hypothesis we isolated ZsGreen þ (T-bet þ ) and ZsGreen À (T-bet À ) IELPs by flow cytometry and differentiated these cells in vitro with recombinant IL-15 ( Figure 4) . The analysis of in vitro cultures by flow cytometry revealed that T-bet þ IELPs had a markedly reduced potential to give rise to CD8ab þ T cells (Figure 4a,b) . To further investigate the inverse correlation between T-bet expression and CD8ab potential, we divided IELPs into four groups representing cells with no, low, intermediate, or high expression of T-bet, as judged by ZsGreen levels (for sorting strategy see Supplementary Figure S3 ). In vitro differentiation of IELPs with different levels of T-bet expression showed a clear inverse correlation between the expression of T-bet and differentiation potential into CD8ab þ T cells (Figure 4c,d) . In fact, T-bet high IELPs had hardly any CD8ab potential in vitro. Although less pronounced, there was ARTICLES MucosalImmunology | VOLUME 11 NUMBER 2 | MARCH 2018 also a reduced potential of T-bet int and T-bet high IELPs to develop into CD8aa þ T cells (Figure 4c,d ). This indicates that the in vitro setting is not able to fully mimic the in vivo situation with its accessory cellular components and soluble mediators.
Although we performed extensive translational profiling by flow cytometry, we could not identify a single marker that could be used as a unique surrogate marker for all T-bet þ IELPs (data not shown). For example, the level of CD122 correlated well with T-bet expression in IELPs (Figure 4e ), but CD122 high cells harbored a mixture of T-bet þ and T-bet À IELPs (Figure 4e ).
Hence and as predicted, in vitro differentiation of these latter cells also gave rise to a sizeable number of CD8ab þ T cells (Figure 4f, lower row) . Of note is that CD122 À IELPs have virtually no potential to blast or to develop into IELs that, therefore, are presumably cells destined for clonal deletion after negative selection (Figure 4f, upper row) . One other interesting feature of the in vitro differentiation experiments was the fact that we reproducibly detected a prominent population of CD8aa þ -expressing cells that were negative for T-bet (Figure 4g, lower right quadrants) . This would imply that some IELs first upregulate CD8aa and then T-bet. However, this pathway might be of minor relevance in vivo as, on average, only 2% of all CD8aa IELs in adult mice are T-bet À (Figure 3d,e) . Hence currently, TBGR mice are ideally suited to identify and sort T-bet high IELPs with a reduced CD8ab þ potential. Next, we wanted to confirm our in vitro data by injecting different IELP populations from TBGR mice into alymphoid Rag2 À / À Il2rg À / À mice ( Figure 5 ). Cells from spleen and intestinal epithelium of Rag2
mice were recovered at least 4 weeks after adoptive transfer. In both organs, the potential of adoptively transferred precursors to develop into TCRab þ CD8ab þ T cells was significantly decreased in mice that had received T-bet þ IELPs compared with mice that had been injected with T-bet À IELPs (Figure  5a 
(a,c) Cells were purified from the spleen or the epithelium of the small intestine of Rag2 À / À Il2rg À / À mice and analyzed by flow cytometry for CD8a and CD8b. Plots were electronically pregated on H2-
lymphocytes from spleen or small intestine pooled from three independent experiments. *Po0.05; **Po0.01; and ***Po0.001. (e) Indicated subsets of flow cytometry sorted TCRab þ IELs from TBGR mice were injected into Rag2 À / À Il2rg À / À mice. Cells were purified from the epithelium of the small intestine or the spleen of Rag2 À / À Il2rg À / À mice 4-8 weeks after transfer and analyzed by flow cytometry for CD8a and CD8b. Plots are pregated on H2-
Numbers represent percentage of cells in gates. Data are representative of four independent experiments. (f) Percentage (mean±s.e.m., n ¼ 6-10) of recovered cells pooled from four independent experiments as described in (e). (g) Indicated subsets of flow cytometry sorted TCRab þ IELs were cultured in 200 ml complete RPMI supplemented with IL-15 (100 ng ml À 1 ) in vitro for 4 days and analyzed for the expression of CD8a and CD8b. Plots are pregated on DAPI À CD3 þ cells, experiments were performed three times, and one representative result is shown.
to test this hypothesis, we sorted mature TCRab þ CD8aa þ , CD8ab þ , and CD8ab À IELs from the epithelium of the small intestine and adoptively transferred them into Rag2
Il2rg
À / À mice. Flow cytometry analysis confirmed that CD8aa þ and CD8ab þ are stable lineages and maintained their expression phenotype in the intestinal epithelium and the spleen (Figure 5e,f) . In contrast, the large majority of TCRab þ
CD8ab
À IELs upregulated CD8aa þ in the epithelium, whereas in the spleen the majority of transferred TCRab þ
À IELs remained CD8aa À (Figure 5e,f) . The cells that upregulated CD8aa in the spleen did so at a lower level than cells that upregulated CD8aa in the intestinal epithelium (see mean fluorescence intensity for comparison in Figure 5e, (Figure 5g , right contour blot). However, we did not obtain the high levels of CD8aa that can be seen in ex vivo TCRab þ CD8aa þ IELs (Figure 5g, 
DISCUSSION
In this study we used bright fluorescent reporter mice for the transcription factor T-bet in order to get unprecedented access to the analysis of T-bet þ IELPs. Expression of T-bet in a subpopulation of IELPs has been appreciated before 4 by antibody staining but usage of TBGR mice with its unique brightness and dynamic range allowed for the first time to determine the developmental potential of these cells in vitro and in vivo. In fact, we show here that the expression level of T-bet þ in thymic IELPs identifies bona fide postselection IELPs at their penultimate step and that IELPs egress from the thymus in a S1P-dependent manner. Eventually, these cells . 20 This discrepancy can best be explained by a model in which immature cells that cannot leave the thymus accumulate and further mature within the thymic microenvironment. Hence, it is possible that IELPs also leave the thymus at an early stage, possibly even before they express high levels of T-bet. This is supported by the analysis of the TCRab þ
CD8ab
À IEL compartment of FTY720-treated mice that shows a significant reduction in T-bet À cells (note that these cells are Qa2 high ) that could therefore be RTEs in untreated TBGR mice (Supplementary Figure S2b) . This would also be in line with the high percentage of T-bet À TCRab þ CD8ab À IELs (Figure 3d ) in the first weeks of life, as this is the time window with the highest frequency of RTEs in the periphery.
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However and as outlined, to formally address the hypothesis that T-bet -/int TCRab þ CD8ab À IELs are RTEs will require the use of Rag1 or Rag2 reporter mice in the future.
Similar to natural IELs, other distinct T-cell subsets such as CD1d-restricted NKT cells and regulatory T cells depend on strong agonist interaction and store-operated calcium entry for their lineage commitment. 21 Presumably, TCR-triggered release of store-operated calcium acts via calcineurin-dependent nuclear translocation of dephosphorylated NFAT1-4 (nuclear factor of activated T-cells 1-4) proteins. Next, NFAT proteins induce the expression of their target genes either on their own or by cooperation with other transcription factors. 22 For example, the transcription factors early growth response-2 and -3 (Egr2 and Egr3) are known target genes of NFAT proteins, 22, 23 and it has been shown recently that Egr2 plays a nonredundant role in the development of NKT cells. 24, 25 So far, the role of Egrs in CD8aa IEL development has not been addressed. The requirement for Egr2 in NKT cells is best explained by their ability to induce the expression of CD122 via binding to its promoter. 25 CD122 is necessary for IL-15 signaling that regulates both NKT and CD8aa IEL development. As a result CD122 À IELPs completely fail to properly respond to IL-15 in our culture system (Figure 4f,g ). Together with a recent report 4 we have shown here that a majority of IELPs (DN NK1.1 À TCRb þ ) express CD122 and Egr2. T-bet, another important regulator of CD122 in the thymus, is not expressed until later stages and correlates inversely with Egr2 expression. Moreover, we show here that IL-15 acts upstream of T-bet (Figure 1k) . It is therefore conceivable that Egr2 is necessary for initial IL-15 responsiveness of IELPs that is later maintained through the action of T-bet on CD122 expression. Hence, we speculate that similar to NKT cells, Egr2 plays a nonredundant role at least during the early stages of IELP development. Importantly, we could also show here that IL-15 not only acts via T-bet, but partially regulates the thymic development of IELPs independent of T-bet. It is crucial to note that despite the strong thymic phenotype of IELPs in Il15 À / À TBGR mice, we do not believe that thymic IL-15 is quintessential for CD8aa þ IEL development. Instead, it is intestinal IL-15 (ref. 26 ) that has to be presented by epithelial cells. 27 The pivotal role of the intestinal epithelial cells for the development of CD8aa þ IELs has been further corroborated by the fact that the transgenic presentation of IL-15 in epithelial cells can rescue the development of CD8aa þ IELs in Il15ra À / À mice. 11 Hence, independent of thymic IL-15, IELPs can survive, migrate to the epithelium, and differentiate into CD8aa þ IELs, even if the intestinal epithelium is the sole source of IL-15. In the future, it will be important to compare Tbx21 À / À TBGR and Il15 À / À TBGR mice side by side in order to decipher the individual contributions of IL-15 and T-bet for IEL development.
As mentioned, NFAT proteins also act by cooperating with other transcription factors. Of particular interest here is the interaction between the myocyte enhancer factor-2D (MEF2D) and NFAT1. 28 This complex jointly transactivates the immediate-early gene Nur77, which identifies thymocytes that received a strong TCR stimulus, e.g., regulatory T cells and NKT cells. Hence, it might be counterintuitive at first that T-bet þ IELPs stop expressing Nur77 (Figure 1k) . However, it must be noted that NKT cells only show strong Nur77 expression at stage 0 in the thymus that then, together with Egr2, declines. 16, 25 In contrast, regulatory T cells show a constant expression of Nur77 in the thymus and the periphery. 16 It could be argued that this is due to the fact that the presentation of the selecting ligand for NKT cells is spatially and temporally tightly regulated. As the selecting ligands for CD8aa IELs are, presumably, ubiquitously expressed MHC class I-restricted self-antigens, this would rather imply that agonist-selected innate-like T cells (i.e., NKT cell, CD8aa þ IELs) have an, for yet unknown reasons, active mechanism to shut down extended Nur77 and Egr2 expression after initial agonist selection and studies are under way to test this notion.
The transcriptional circuits that regulate the development of natural IELs have just begun to be delineated. With the aid of TBGR mice, anatomic location, and surface markers, we are now able to identify three sequential stages of natural IEL development after selection. In the future this will allow us to generate a dynamic molecular framework of natural IEL development, advance our understanding of natural IEL biology, and provide a new starting point to harness the potency of natural IELs to ameliorate intestinal immunopathology. À / À Il2rg À / À on a BALB/c background were bred locally. Animals were between 6 and 16 weeks of age if not otherwise indicated. All animal experiments were approved and are in accordance with the local animal care committees.
METHODS
Isolation of IELs, thymocytes, or splenocytes. Isolation of IELs was carried out as previously described. 4 In brief, small intestine was removed, cleaned from remaining fat tissue, and Peyer's patches were identified and eliminated. Small intestine was opened longitudinally with a scissor and washed in ice-cold phosphate-buffered saline (PBS). Dissociation of epithelial cells was performed by incubation at 37 1C in Hanks' balanced salt solution containing 5 mM EDTA or 1 mM dithiothreitol and 10 mM Hepes twice for 20 min and mechanical force with the vortexer after each incubation step. Leukocytes were further enriched by Percoll (Sigma-Aldrich, Munich, Germany) gradient centrifugation. For isolation of IELs for transfer experiments or in vitro differentiation, 6-8 small intestines were pooled and labeled with 4',6-diamidino-2-phenylindole (DAPI), anti-CD45.2, anti-CD4, TCRgd, anti-TCR-b, anti-CD8a, and anti-CD8b to sort the three IEL populations DAPI -CD45 þ CD4 À TCRab þ CD8ab À , CD8aa þ , and CD8ab þ , respectively. Thymus was removed and mashed through a 70 mm cell strainer (BD Biosciences, Heidelberg, Germany) with 10 ml of PBS. After centrifugation, erythrocytes were removed through incubation in red cell lysis buffer. For isolation of IELPs for transfer experiments or in vitro differentiation, 6-8 thymi were pooled and the majority of double-and single-positive thymocytes were depleted by incubation with purified rat anti-CD4 (GK1.5) and antiCD8b (YTS156.7.7) antibody (both from Biolegend, San Diego, CA), followed by anti-rat Dynabeads (Life Technologies, Carlsbad, CA) according to the manufacturer's protocol. For verification of efficient negative selection, gating, and sorting of viable thymic IELPs (DAPI
